Keytruda SC Overview

Back

Overview
SC Benefit
MK-3475A-D77 Study
Summary

AE-KEY-01096 | Exp 2 Feb 2028

Login

Loading...

Need an account? Register

What can we help you find?

Search for

Contact Us
Terms of Use
Privacy Policy
Site Map
Accessibility

AE-NON-00555 | Exp: 12 June 2027
To report an adverse event, product quality complaint and other reportable information or if you have a medical inquiry, you can contact: Tel: +9714 4269100 Fax: +9714 4269204

Email: DPOC.GULF@MSD.COM

AE-NON-00555 | Exp: 12 June 2027
To report an adverse event, product quality complaint and other reportable information or if you have a medical inquiry, you can contact: Tel: +966112506700 Fax: +966 11 2506870
Email: DPOC.SAUDI@MSD.COM
MSD Building #3, Business Gate, Airport Road, Qurtubah, Riyadh 13244 PO Box 17098 Saudi Arabia.

This site uses cookies. To find out more about the cookies this site uses and how to manage them, please review the cookies section of our Privacy Policy. By using the site, you agree to our use of cookies.

Keytruda SC Overview

MK-3475A-D77 Study Design

KEYTRUDA SC Consistent Pharmacokinetics

Secondary End Points

KEYTRUDA SC: Safety Consistent With KEYTRUDA IV